The survival analysis demonstrated that ITK high-expression BC patients had a surprisingly longer OS time than ITK low-expression BC patients (p = 0.009), highlighting a positive connection between ITK expression and prognosis of patients with BC (Figure 6A). The gene discussed is ITK; the disease is breast cancer.